Guidelines Flashcards
What is the criteria for Level 1 Evidence?
Meta-analysis with narrow confidence intervals and/or 2 or more RCTs with adequate sample size, preferably placebo controlled
What is the criteria for Level 2 Evidence?
Meta-analysis with wide confidence intervals and/or 1 or more RCTs with adequate sample size
What is the criteria for Level 3 Evidence?
Small-sample RCTs or nonrandomized, controlled prospective studies or case series or high-quality retrospective studies
What is the criteria for Level 4 Evidence?
Expert opinion/consensus
According to CANMAT, how does a recommendation become first line?
Level 1 or Level 2 Evidence, plus clinical support
According to CANMAT, how does a recommendation become second line?
Level 3 Evidence or higher, plus clinical support
According to CANMAT, how does a recommendation become third line?
Level 4 Evidence or higher, plus clinical support
According to CANMAT Depression Guidelines (2016), what medications are first line?
(Long answer)
Remember - SSRIs, SNRIs, NDRI, “MMAV”
- All SSRIs
- Escitalopram
- Citalopram
- Fluoxetine
- Fluvoxamine
- Paroxetine
- Sertraline
- All SNRIs (minus Levomilnacipran)
- Duloxetine
- Venlafaxine
- Desvenlafaxine
- Milnacipran
- NDRI
- Bupropion
- a2-Adrenergic agonist; 5-HT2 antagonist
- Mirtazapine
- Mianserin
- 2 Others
- Agomelatine (MT1 and MT2 agonist; 5-HT2 antagonist)
- Vortioxetine (Serotonin reuptake inhibitor; 5-HT1A agonist; 5-HT1B partial
agonist; 5-HT1D, 5-HT3A, and 5-HT7 antagonist)
According to CANMAT Depression Guidelines (2016), what medications are second line?
Remember: TCAs, Quetiapine, LevoM, MAOS, and “dones”
- TCAs
- Amitriptyline, domipramine, desipramine, nortriptyline, etc
- Quetiapine
- Levomilnacipran (SNRI)
- Moclobemide (Reversible Inhibitor of MAO-A)
- Selegeline (Irreversible Inhibitor of MAO-B)
- Trazodone (Serotonin reuptake inhibitor; 5-HT2 antagonist)
- Vilazodone (Serotonin reuptake inhibitor; 5-HT1A partial agonist)
According to CANMAT Depression Guidelines (2016), what medications are third line?
- Irreversible MAOs
- Phenelzine
- Tranylcypromine
- Reboxetine (Noradrenaline reuptake inhibitor)
According to CANMAT, what factors should you consider in selecting an antidepressant?
- Patient Factors
- Clinical Features
- Comorbid Conditions
- Response and Side Effects during previous trials
- Patient Preference
- Medication Factors
- Comparative efficacy
- Side Effects /Comparative Tolerabilty
- Potential Interactions
- Ease of use
- Cost and availability
According to CANMAT Depression Guidelines (2016), what are the reccommendations for MDD with anxious distress?
- Use antidepressant with efficacy in GAD
- No difference between SSRI, SNRI, Bupropion
According to CANMAT Depression Guidelines (2016), what are the reccommendations for MDD with catatonia?
Benzodiazepenes
According to CANMAT Depression Guidelines (2016), what are the reccommendations for MDD with melancholic features?
No antidepressants have demonstrated efficacy
According to CANMAT Depression Guidelines (2016), what are the reccommendations for MDD with atypical features?
No antidepressants showed superiority
(Older studies found MAOs >TCAs)
According to CANMAT Depression Guidelines (2016), what are the reccommendations for MDD with psychotic features?
Use antidepressant and antipsychotic co-treatment
According to CANMAT Depression Guidelines (2016), what are the reccommendations for MDD with mixed features?
Lurasidone
Ziprasidone
According to CANMAT Depression Guidelines (2016), what are the reccommendations for MDD with seasonal pattern?
No antidepressants have demonstrated superiority
According to CANMAT Depression Guidelines (2016), what are the reccommendations for MDD with cognitive dysfunction?
Vortioxetine (level 1)
SSRIs
Bupropion
Duloxetine
Moclobemide
According to CANMAT Depression Guidelines (2016), what are the reccommendations for MDD with sleep disturbance?
Agomelatine
Mirtazpine
Trazodone
Quetiapine
(Weigh against potential for side effects)
According to CANMAT Depression Guidelines (2016), what are the reccommendations for MDD with somatic symptoms?
Pain
- Duloxetine - Level 1
- Other SNRIs - Level 2
Fatigue
- Bupropion - Level 1
- SSRIs - Level 2
Low Energy
- Duloxetine - Level 2
What are risk factors to consider longer term (2 years or longer) maintenance treatment with antidepressants?
- Frequent, recurrent episodes
- Severe episodes (psychosis, severe impairment, suicidality)
- Chronic episodes
- Presence of comorbid psychiatric or other medical conditions
- Presence of residual symptoms
- Difficult-to-treat episodes
After you have selected and initiated a first line antidepressant, how long do you wait to determine whether there is early improvement?
2-4 weeks
You have started an antidepressant, and there is early improvement after 2-4 weeks. What do you do next?
Keep patient on treatment for 6-8 weeks, then reassess
You have started an antidepressant that showed some early improvement after 4 weeks. 8 weeks later, patient has full symptom remission. How long do you keep them on treatment?
- 6-9 months
- 2 years or longer if risk factors for recurrence
You have started a first line antidepressant. After 4 weeks, there is no early improvement. What is your next step?
- Consider Factors for switch vs adjunct
- Depending on tolerability, first optimize by increasing dose
- Switch to antidepressant with superior efficacy OR
- Add an adjunctive medication
- After failure of 1 or more antidepressants, consider switching to second or thrid line agent
- For early treatment resistance, consider adjunct use of psychological and neurostimulation treatments
According to CANMAT, what are first line recommendations for adjunctive medications for nonresponse or partial response to an antidepressant?
Aripiprazole
Quetiapine
Risperidone
According to CANMAT, what are second line recommendations for adjunctive medications for nonresponse or partial response to an antidepressant?
Brexpiprazole
Bupropion
Lithium
Mirtazapine
Mianserin
Modafinil
Olanzapine
Triiodothyronine (T3)
According to CANMAT, what are third line recommendations for adjunctive medications for nonresponse or partial response to an antidepressant?
- Other antidepressants
- Other stimulants
- TCAs
- Ziprasidone
According to CANMAT, what is an experimental recommendation for adjunctive treatment for nonresponse or partial response to an antidepressant?
Ketamine
What are factors to consider in choosing between switching to another antidepressant monotherapy or adding an adjunctive medication?
Consider SWITCHING when
- It is the first antidepressant trial
- Poorly tolerated side effects to initial
- No response (<25% improvement) to initial
- you have more time to wait for a response (less severe, less impairment)
- Pt prefers to switch
Consider adjunctive when
- there have been 2 or more antidepressants tried
- Initial antidepressant is well tolerated
- There is partial response (>25% improvement) to initial AD
- There are specific residual symptoms or side effects to the initial antidepressant that can be targeted.
- There is less time to wait for a response (more severe, more functional impairment).
- Patient prefers to add on another medication
What does CANMAT say about managing persistent and chronic depression (PDD)?
- SSRIs similar in efficacy to TCAs but better tolerated
- atients with repeated treatment failures and a chronic course of depression may require a chronic disease management approach (i.e., with less emphasis on remission of symptoms and cure, greater emphasis on improving func- tioning and quality of life, and greater use of psychotherapeutic and nonmedication treatments)
What are first line psychological treatments for acute and maintenance treatment of MDD?
CBT
IPT
Behavioural Activation
What are second line psychological treatments for acute and maintenance treatment of MDD?
Mindfulness Based CBT (MCBT)
Cognitive Behavioural Analysis System of Psychotherapy (CBASP)
Problem-Solving Therapy (PST)
Short Term Psychodynamic Psychotherapy (STPP)
Telephone delivered CBT and IPT
Internet and computer assisted therapy
What are third lline psychological treatments for acute and maintenance treatment of MDD?
Long term psychodynamic
Acceptance and Commitment Therapy (ACT)
Videoconferenced Psychotherapy
Motivational Interviewing (MI)
What is the impact of comorbid anxiety on psychological treatments in MDD?
- Anxiety likely doesn’t complicate or reduce response to tx
- CBT more beneficial than other psychological treatments
What is the impact of comorbid substance abuse on psychological treatments in MDD?
- CBT improves both depression and substance abuse symptoms
- Integrated treatment is effective but with small effect size
What is the impact of comorbid personality disorders on psychological treatments in MDD?
- PDs have negative impact on depression outcomes
What is the impact of comorbid ADHD on psychological treatments in MDD?
CBT for ADHD helps both disorders, as adjunct to medications
What is the impact of comorbid HIV on psychological treatments in MDD?
CBT effective, mostly in group
IPT may be effective but limited studies
What is the impact of comorbid Parkinson’s Disease on psychological treatments in MDD?
CBT effective for reducing depressive symptoms
Which neurostimulation technique(s) are first line treatments for MDD?
rTMS
ECT (in some situations)
*both in acute and maintenance
Which neurostimulation technique(s) are second line treatment for MDD?
ECT (if no specific indication making it first line)
Which neurostimulation technique(s) are third line treatments for MDD?
Transcranial Direct Current Stimulation (tDCS)
Vagus Nerve Stimulation (VNS)
What is the first line reccommendation for rTMS stimulation protocols?
High frequency rTMS to left DLPFC (>10Hz)
Low frequency rTMA to right DLPFC (<1Hz)
How is rTMS delivered?
- Powerful (1-2.5 Tesla) focused magnetic field impulses to induce electrical currents in neural tissue, vis inductor coil placed on scalp
- Usually delivered by tech or nurse, under MD supervision
- no anaesthesia required
- 1x daily, 5 x/week
How many sessions are required for rTMS?
- Initial course until remission is achieved, up to 20 sessions
- Extend course up to 30 sessions in responders who haven’t achieved remission
- Use rTMS PRN to maintain response
How does rTMS compare to ECT?
- ECT more effective
- rTMS should be considered prior to ECT, as pts who did not respond to ECT are unlikely to respond to TMS
What are the clinical indications for ECT as a first-line treatment for MDD?
- Acute SI
- Psychotic Features
- Treatment Resistant Depression
- Repeated med intolerance
- Catatonic Features
- Prior good response to ECT
- Rapidly deteriorating physical status
- During pregnancy, for any of the above indications
- Patient preference
What are absolute contraindications to ECT?
There are none
Which conditions may be associated with an increased safety risk for ECT?
- Space occupying lesion
- Increased ICP
- recent MI
- recent cerebral hemmorhage
- unstable vascular anaeurysm/malformation
- Pheochromocytoma
- Class 4 or 5 anasthesia risk
What are absolute contraindications to rtMS?
- Metallic hardware anywhere in the head (except the mouth)
- Eg. cochlear implants, brain stimulators or electrodes, aneurysm clips
What are relative contraindications to rtMS?
Cardiac Pacemaker
Implantable defibrillator
Hx Epilepsy
Presence of brain lesion
What are the first line recommendatiosn for delivery of ECT?
Brief Pulse, Right unilateral (5-6x sz threshold)
Brief Pulse, Bifrontal (at 1.5-2 x sz threshold)
How many treatments are required for ECT?
Index Course ranges from 6-15
Delivered 2-3x per week
How effective is ECT as a treatment for MDD?
70-80%
When are ECT relapse rates the highest?
In first 6 months post ECT (37.7%)
What is the mortality rate for ECT?
1 death/73,440 treatments
What are most common adverse effects of ECT?
Headache
Muscle Soreness
Nausea
What type of cognitive side effects are seen in ECT?
- transient disorientation
- retrograde amneia
- anterograde amneisa
But MILD and short term
What factors are associated with higher rates of short term adverse cognitive effects of ECT? (vs those associated with lower rates)
- Bitemporal electrode placement vs bifrontal or nilateral
- Brief pulse width vs ultrabrief pulse
- suprathreshold stimulation vs lower elctrical dose
- Treatment 3x/week vs 2x/week
- Use of lithium vs lower dose or discontinuing lithium
- Use of high doses anaesthetic agent vs lower doses
What are first line complementary and alternative treatments in MDD?
Light Therapy (Seasonal MDD)
Exercise (Mild to Moderate MDD)
What are reccommendations for exercise as treatment for MDD?
30 mins of supervised moderate intensity exercise at least 3x/week for minimm 9 weeks
What are second line reccommendations for physicial and meditative treatments of depression?
Exercise (Moderate to Severe MDD)
Light therapy (non-seasonal mild to moderate MDD)
Yoga (Mild to moderate MDD)
What is a first line natural health product as treatment for depression?
St. John’s Wort (Mild to Moderate)
What are second line natural health products as treatment for depression?
St. John’s Wort (moderate to severe MDD)
Omega 3
SAM-e
According to CANMAT, what is first line treatment of MDD in children and youth?
CBT
IPT
Internet-based psychotherapy (milder severity, if in-person not possible)
According to CANMAT, what is first line treatment of MDD in children and youth?
Fluoxetine (Level 1)
Escitalopram, sertraline, citalopram (Level 2)
According to CANMAT, what is third line treatment of MDD in children and youth?
Venlafaxine
TCA
According to CANMAT, what is true about suicide prevention in children and youth?
- CBT for suicide prevention combined with pharmacotherapy resulted in greatest improvements in depressed youth who had recently attempted suicide
- CBT alone resulted in greatest improvements in depressed youth who had recently attempted suicide
- Pharmacotherapy alone resulted in greatest improvements in depressed youth who had recently attempted suicide
- CBT + pharmacotherapy = pharmacotherapy alone resulted in improvements in depressed youth who had recently attempted suicide
CBT for suicide prevention combined with pharmacotherapy resulted in greatest improvements in depressed youth who had recently attempted suicide
According to CANMAT, what is the evidence of paroxetine in treating children and youth with depression?
Paroxetine has not shown efficacy in this age group
What precautions should one take in prescribing citalopram in children?
- Children with long QT should not be treated with citalopram
- Children with congenital heart disease or hepatic impairment sould be treated with caution
When would you choose pharmacotherapy before a trial of psychotherapy in children?
- If psychotherapy not accessivle, acceptable, or effective in moderate MDD
- In more severe cases of depression
Hoq frequently should children be monitored after initiating treatment with an antidepressant?
- Weekly for first 4 weeks
- Then visits every 2 weeks for a month
- Then after 12 weeks to monitor adverse events/SI
When starting antidepressant in youth, how do you dose?
- Start at low end of therapeutic range
- Continue at least 4 weeks before considering dose increase
- If 12 weeks of adequate dosing, and pt shows only partial response, switch
How long should children with MDD be treated with pharmacotherapy?
- 12 months if severe or 2 episodes
- Otherwise, 6-12 months
Which antidepressants has Health Canada approved under the age of 18?
None!
What is the warning associated with use of antidepressants in patients 24 and younger?
Black Box Warning, increased suicidal thoughts/behaviours
Maternal/Perinatal Depression is associated with the following poor outcomes accoridng to CANMAT:
- Poor obstetrical outcomes
- SGA
- NICU
- Increased rates neonatal complications
- impairment in bonding
- infant sleep difficulties
- developmental delay
- cognitive, behavioural, emotional problems in offspring
What is first line treatment of mild to moderate MDD during pregnancy according to CANMAT?
CBT
IPT
What is second line treatment of mild to moderate MDD in pregnancy according to CANMAT?
Citalopram
Escitalopram
Sertraline
What is first line treatment of severe MDD in pregnancy according to CANMAT?
Citalopram
Escitalopram
Sertraline
(either alone, or in combo with CBT/IPT. Psychotehrapy monotherapy NOT reccommended)
What is second line treatment of severe MDD in pregnancy according to CANMAT?
Buproprion
Desvenlafaxine
Duloxetine
Fluoxetine
Fluvoxamine
Mirtazapine
TCAs
Venlafaxine
What “line” of reccommendation is ECT in severe/psychotic/tx resistant MDD in pregnancy AND breastfeeding?
Third Line
Which antidepressants have the lowest RID (relative infant dose) and milk to plasma ratios?
Setraline
Fluvoxamine
Paroxetine
What is second line treatment of Mild to Moderate Postpartum Depression During Breastfeeding?
Citalopram
Escitalopram
Setraline
Combo of the above + CBT/IPT
What is first line treatment of severe Postpartum Depression During Breastfeeding?
Citalopram
Escitalopram
Setraline
Combo above + CBT/IPT
What is second line treatment of severe Postpartum Depression During Breastfeeding?
Fluoxetine
Fluvoxamine
Paroxetine
TCAs (except doxepin - v high rate of passage into breast milk)
Bupropion
Desvenlafaxine
Duloxetine
Mirtazapine
Venlafaxine
What is the first line reccommendation for treatment of perimenopausal depression?
Desvenlafaxine
CBT
What is the second line reccommendation for treatment of perimenopausal depression?
Trasndermal Estradiol (level 2)
Citalopram (Level 3)
Duloxetine
Escitalopram
Mirtazapine
Quetiapine XR
Venlafaxine XR
Fluoxetine (Level 4)
Nortriptyline
Paroxetine
Sertraline
Omega 3
What is the first line reccommendation for treatment of late life depression according to CANMAT?
Duloxetine (level 1)
Mirtazapine
Nortriptyline
Bupropion (Level 2)
Citalopram
Escitalopram
Desvenlafaxine
Duloxetine
Sertraline
Venlafaxine
Vortioxetine
What is the second line reccommendation for treatment of late life depression according to CANMAT?
- Switch to
- Notriptyline
- Moclobemide
- Phenelzine
- Quetiapine
- Trazodone
- Bupropion
- Combine with
- Aripiprazole
- Lithium
- Methyphenidate
According to Katzman, what is the role of benzos in anxiety disorders?
May be useful as adjunct early in tx
In acute crises
Or wiating for onset of efficacy of SSRIs/antidepressants
According to Katzman, in anxiety disorders, how long does it take for pharmacological treatment to be effective?
2-8 weeks in onset of symptom relief
Full response in 12 weeks or longer
According to Katzman, how long should therapy continue for?
Longer term therapy associated with continued symptom improvement and relapse prevention
Therapy shoul dbe continued 12-24 months for most patients
According to Katzman, how should medications be dosed in anxiety disroders?
Initiate at low doses
Titrate to reccommended dosage at 1-2wk intervals over 4-6 weeks
Once therapeutic range achieved, improvement in next 4-8 weeks
F/u at 2 wk intervals for first 6 wks, then monthly
According to Katzman what objective scales can be used to assess a patient’s progress?
Clinical Global Impression (CGI) scale
Hamilton Anxiety Rating Scale (HARS)
According to Katzman in panic disorder, what is true about the effectiveness of CBT vs medications?
CBT was significantly favored over medications for the treatment of panic disorder in a meta-analysis
According to Katzman in Panic Disorder, what type of CBT techniques had the most consistent evidence of efficacy?
Exposure
Cognitive restructuring
Other CBT techniques
According to Katzman in panic disorder, what is true about combination psychotherapy + pharmacotherapy with antidepressants?
Superior to CBT or pharmacotherapy alone during acute treatment and while meds continued
After terminatin of therapy, combined therapy was MORE effective than pharmacotherapy alone and AS effective as psychotherapy
According to Katzman in Panic Disorder, what are first line reccommendations for pharmacotherapy?
- SSRIs
- Citalopram
- Escitalopram
- Fluoxetine
- Fluovoxamine
- Paroxetine
- Sertraline
- Venlafaxine